GEODE CAPITAL MANAGEMENT, LLC

Holdings History for ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP)

Symbol: ORMP on Nasdaq
Investment type: Equity / Common Stock par value $0.012 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$69,203	24,282	0		$2.85	Q4 2025
30 Sep 2025	0%	0%	$64,104	24,282	0		$2.64	Q3 2025
30 Jun 2025	0%	0%	$54,634	24,282	-1,173	-4.6%	$2.25	Q2 2025
31 Mar 2025	0%	0%	$54,473	25,455	0		$2.14	Q1 2025
31 Dec 2024	0%	0%	$61,601	25,455	0		$2.42	Q4 2024
30 Sep 2024	0%	0%	$62,110	25,455	0		$2.44	Q3 2024
30 Jun 2024	0%	0%	$65,419	25,455	0		$2.57	Q2 2024
31 Mar 2024	0%	0%	$74,328	25,455	0		$2.92	Q1 2024
31 Dec 2023	0%	+0%	$58,801	25,455	+4,546	+22%	$2.31	Q4 2023
30 Sep 2023	0%	0%	$54,572	20,909	0		$2.61	Q3 2023
30 Jun 2023	0%	+0%	$74,854	20,909	+2,779	+15%	$3.58	Q2 2023
31 Mar 2023	0%	0%	$39,523	18,130	0		$2.18	Q1 2023
31 Dec 2022	0%	0%	$218,000	18,130	0		$12.02	Q4 2022
30 Sep 2022	0%	0%	$117,000	18,130	0		$6.45	Q3 2022
30 Jun 2022	0%	-0%	$83,000	18,130	-303,029	-94%	$4.58	Q2 2022
31 Mar 2022	0%	+0%	$2,778,000	321,159	+75,814	+31%	$8.65	Q1 2022
31 Dec 2021	0%	-0%	$3,503,000	245,345	-1,626	-0.66%	$14.28	Q4 2021
30 Sep 2021	0%	+0%	$5,428,000	246,971	+29,263	+13%	$21.98	Q3 2021
30 Jun 2021	0%	+0%	$2,912,000	217,708	+200,751	+1184%	$13.38	Q2 2021
31 Mar 2021	0%	0%	$172,000	16,957	0		$10.14	Q1 2021
31 Dec 2020	0%	0%	$71,000	16,957	0		$4.19	Q4 2020
30 Sep 2020	0%	0%	$44,000	16,957	0		$2.59	Q3 2020
30 Jun 2020	0%	0%	$59,000	16,957	0		$3.48	Q2 2020
31 Mar 2020	0%	0%	$51,000	16,957	0		$3.01	Q1 2020
31 Dec 2019	0%	0%	$87,000	16,957	0		$5.13	Q4 2019
30 Sep 2019	0%	0%	$54,000	16,957	0		$3.18	Q3 2019
30 Jun 2019	0%	+0%	$60,000	16,957	+16,957	NEW	$3.54	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.